Heartseed

  • NEWS
  • PIPELINE
  • TECHNOLOGY
  • ABOUT US
    • CEO Message
    • Purpose
    • Company Profile
    • Management
  • Mission & Values
  • CONTACT
  • JP/EN
  1. HOME
  2. NEWS
  3. Media

Media

2023319

Media News article about the initiation of a clinical trial of Heartseed was published in Nature Medicine.

2022620

Media Interview with Keiichi Fukuda was published in "Features", Keio University School of Medicine.

202267

Media Interview with Takehiko Kaneko, CMO and Head of R&D at Heartseed, was published in RegMedNet.

2022128

Media Heartseed was featured by NHK World's CATCH JAPAN.

2022111

Media An interview with Kikuo Yasui, COO was published in Venture Valuation.

20211124

Media Featured Story on Heartseed was listed on Science Japan by Japan Science and Technology Agency (JST).
"Developing a next-generation therapy for severe heart failure using iPS cells"

2021510

Media An interview with Kikuo Yasui, COO, was published in the Japan Times.

2021421

Media Heartseed was featured as a cover story in Startup City Magazine's "Top 10 Startups in Japan"

2020129

Media Links of Keiichi Fukuda' interviews were posted at CEO Message.

1

COMPANY OVERVIEW

To transform treatment of severe heart failure by delivering cardiac regenerative medicine, Heartseed Inc. was founded in 2015. It has also been developing technologies to expand the access of RM.

Company name
Heartseed Inc.
Head Office
The Artcomplex Center of Tokyo #302, 12-9, Daikyo-cho, Shinjuku-ku, Tokyo 160-0015, JAPAN
Contact
contact@heartseed.jp

MORE VIEW

MORE VIEW

MENU

  • Home
  • News
  • PIPELINE
  • TECHNOLOGY
  • About us
  • Mission & Values
  • Contacts

language

  • English
  • Japanese
  • GO TO TOP

Copyright © All Rights Reserved HEARTSEED HEARTSEED